Stolz et al., 2020 - Google Patents
Capillary zone electrophoresis-top-down tandem mass spectrometry for in-depth characterization of hemoglobin proteoforms in clinical and veterinary samplesStolz et al., 2020
View PDF- Document ID
- 6841416426847938295
- Author
- Stolz A
- Hedeland Y
- Salzer L
- Römer J
- Heiene R
- Leclercq L
- Cottet H
- Bergquist J
- Neusüß C
- Publication year
- Publication venue
- Analytical chemistry
External Links
Snippet
Hemoglobin (Hb) constitutes an important protein in clinical diagnostics—both in humans and animals. Among the high number of sequence variants, some can cause severe diseases. Moreover, chemical modifications such as glycation and carbamylation serve as …
- 102000001554 Hemoglobins 0 title abstract description 65
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/723—Glycosylated haemoglobin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stolz et al. | Capillary zone electrophoresis-top-down tandem mass spectrometry for in-depth characterization of hemoglobin proteoforms in clinical and veterinary samples | |
Thompson et al. | TMTpro: design, synthesis, and initial evaluation of a proline-based isobaric 16-plex tandem mass tag reagent set | |
Valentine et al. | Toward plasma proteome profiling with ion mobility-mass spectrometry | |
Panchaud et al. | Faster, quantitative, and accurate precursor acquisition independent from ion count | |
Aldredge et al. | Annotation of a serum N-glycan library for rapid identification of structures | |
Chen et al. | Online hydrophobic interaction chromatography–mass spectrometry for top-down proteomics | |
Edwards et al. | Top-down proteomics and direct surface sampling of neonatal dried blood spots: diagnosis of unknown hemoglobin variants | |
Gatlin et al. | Automated identification of amino acid sequence variations in proteins by HPLC/microspray tandem mass spectrometry | |
Zhang et al. | Protein analysis by shotgun/bottom-up proteomics | |
Wu et al. | Novel LC-MS2 product dependent parallel data acquisition function and data analysis workflow for sequencing and identification of intact glycopeptides | |
Zoanni et al. | Novel insights about albumin in cardiovascular diseases: Focus on heart failure | |
Zhang et al. | Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects | |
Valeja et al. | Three dimensional liquid chromatography coupling ion exchange chromatography/hydrophobic interaction chromatography/reverse phase chromatography for effective protein separation in top-down proteomics | |
Haselberg et al. | Capillary electrophoresis–mass spectrometry for the analysis of intact proteins 2007–2010 | |
Redman et al. | Analysis of hemoglobin glycation using microfluidic CE-MS: a rapid, mass spectrometry compatible method for assessing diabetes management | |
Yu et al. | Quantitative top-down proteomics in complex samples using protein-level tandem mass tag labeling | |
van den Broek et al. | Quantifying protein measurands by peptide measurements: where do errors arise? | |
Smit et al. | The time has come for quantitative protein mass spectrometry tests that target unmet clinical needs | |
Fernandez-Fernandez et al. | Simultaneous determination of creatinine and creatine in human serum by double-spike isotope dilution liquid chromatography–tandem mass spectrometry (LC-MS/MS) and gas chromatography–mass spectrometry (GC-MS) | |
Bergmann et al. | Application of metal-coded affinity tags (MeCAT): absolute protein quantification with top-down and bottom-up workflows by metal-coded tagging | |
Sabbagh et al. | Clinical applications of MS‐based protein quantification | |
Nepomuceno et al. | Accurate identification of deamidated peptides in global proteomics using a quadrupole orbitrap mass spectrometer | |
Böhm et al. | Low-pH solid-phase amino labeling of complex peptide digests with TMTs improves peptide identification rates for multiplexed global phosphopeptide analysis | |
Mischak et al. | High‐resolution proteome/peptidome analysis of peptides and low‐molecular‐weight proteins in urine | |
Behnken et al. | Glycan analysis of Prostate Specific Antigen (PSA) directly from the intact glycoprotein by HR-ESI/TOF-MS |